GPT-4 Successor; Colorado’s AI Law; AI Clinical Notes Boom

Welcome to MedAI Roundup, highlighting the latest news and research in healthcare-related artificial intelligence each month.

OpenAI said it has begun training a new flagship AI model that will succeed its GPT-4 technology. (New York Times)

Colorado became the first state to pass a law regulating the use of AI for critical decision-making, including patient care. It doesn’t go into effect until 2026. (Politico)

Health insurers say they’re increasingly using AI, but few have shared specifics about which models they’re using or how they’re being implemented. (STAT News)

AI promises to supercharge drug development, but experts warn that marketing hype might overheat the industry. (STAT News)

In a study of 500 emergency department patient pairs published in JAMA Network Open, a large language model accurately identified the higher acuity patient 89% of the time.

A study in JAMA Oncology found that chatbots can generate quality, empathetic, and readable responses to patient questions posted on social media.

NIH Director Monica Bertagnolli, MD, wrote in a blog post that an AI model could help speed the diagnosis of rare genetic disorders.

Doctors at the University of Chicago Medicine will have access to Abridge’s clinical documentation platform, which includes drafting a note in real-time based on conversations between the clinician and the patient, the company announced.

Microsoft’s Nuance announced that Utah-based Intermountain Health will begin using its Dragon Ambient eXperience (DAX) Copilot generative AI product to automate clinical documentation and administrative tasks.

And Suki said it has partnered with Premier to offer its AI-powered virtual assistant — which listens to patient-clinician conversations and automatically drafts clinical notes — to the network’s 4,000-plus hospitals.

Please enable JavaScript to view the

comments powered by Disqus.